指南与共识牙周病牙体牙髓病

牙周病与糖尿病关联的科学证据:IDF与EFP联合共识报告及指南

Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology.
指南 / 共识 · J Clin Periodontol · 2017-12-26

国际糖尿病联盟与欧洲牙周病学联合会联合发布共识,更新牙周病与糖尿病双向关系的流行病学与机制证据,并重新评估牙周治疗对代谢控制的影响。共识指出牙周炎患者血糖异常和胰岛素抵抗风险升高,牙周治疗可使HbA1C降低0.27-0.48%,推荐加强早期诊断与协同管理。

要点

  • 牙周炎患者血糖异常和胰岛素抵抗风险升高,牙周炎与2型糖尿病发病风险增加相关。
  • 糖尿病患者中牙周炎患者HbA1C显著高于牙周健康者,但1型糖尿病数据不足。
  • 牙周治疗安全有效,3个月后HbA1C降低0.27-0.48%,长期随访证据不确定。

核心结论

  • 牙周病与糖尿病存在双向关系,EFP与IDF发布共识指南以改善早期诊断、预防和协同管理。

研究设计与样本

  • EFP与IDF联合 workshop 制定的共识报告与指南,基于流行病学、机制和干预证据的更新。

主要发现

  • 牙周炎患者血糖异常和胰岛素抵抗风险升高。
  • 糖尿病患者中牙周炎患者HbA1C显著高于牙周健康者,但1型糖尿病数据不足。
  • 牙周炎与2型糖尿病发病风险增加相关。
  • 机制涉及IL-1-β、TNF-α、IL-6、RANKL/OPG比值、氧化应激及TLR2/4表达升高。

关键数值与推荐

  • 牙周治疗3个月后HbA1C降低0.27-0.48%,长期随访研究结论不一致。

临床怎么用

  • 口腔科医生应关注牙周炎患者的糖尿病筛查与早期诊断。
  • 对糖尿病患者进行牙周评估,牙周治疗安全有效,可辅助改善血糖控制。
  • 推动医生、口腔卫生专业人员和患者之间的协同管理。

局限性

  • 1型糖尿病患者中牙周炎与HbA1C关联的数据不足。
  • 牙周治疗对HbA1C长期影响的随访研究结论不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes and periodontitis are chronic non-communicable diseases independently associated with mortality and have a bidirectional relationship. AIMS: To update the evidence for their epidemiological and mechanistic associations and re-examine the impact of effective periodontal therapy upon metabolic control (glycated haemoglobin, HbA1C). EPIDEMIOLOGY: There is strong evidence that people with periodontitis have elevated risk for dysglycaemia and insulin resistance. Cohort studies among people with diabetes demonstrate significantly higher HbA1C levels in patients with periodontitis (versus periodontally healthy patients), but there are insufficient data among people with type 1 diabetes. Periodontitis is also associated with an increased risk of incident type 2 diabetes. MECHANISMS: Mechanistic links between periodontitis and diabetes involve elevations in interleukin (IL)-1-β, tumour necrosis factor-α, IL-6, receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio, oxidative stress and Toll-like receptor (TLR) 2/4 expression. INTERVENTIONS: Periodontal therapy is safe and effective in people with diabetes, and it is associated with reductions in HbA1C of 0.27-0.48% after 3 months, although studies involving longer-term follow-up are inconclusive. CONCLUSIONS: The European Federation of Periodontology (EFP) and the International Diabetes Federation (IDF) report consensus guidelines for physicians, oral healthcare professionals and patients to improve early diagnosis, prevention and comanagement of diabetes and periodontitis.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Sanz M, Ceriello A, Buysschaert M, et al. Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology. J Clin Periodontol. 2017. PMID: 29280174. doi:10.1111/jcpe.12808

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。